Our providers offer state-of-the-art treatments for patients with all forms of liver disease. By participating in clinical trials of new therapies, the institute is able to provide many patients with early access to potentially life-saving treatments before they are available to the general public. Clinical trials are performed in collaboration with the pharmaceutical/device industry as well as the National Institutes of Health.
Areas of research at the institute include:
Treatment of Viral Hepatitis B and C
Treatment of Complications of Cirrhosis
Hepatorenal Syndrome
Hepatic Encephalopathy
Metabolic Dysfunction-Associated Steatotic Liver Disease
Treatment Outcomes
Current Clinical Trials
Clinical trials often involve a research study conducted to evaluate a medical procedure or medical product, such as a drug. Not all University of Arizona studies involve drugs or interventions. Some studies use surveys or evaluate medical records to find new and better ways to help people. Others recruit healthy subjects, or controls, to better evaluate and compare results with those of non-healthy subjects. Find clinical trials currently recruiting patients in these categories:
Clinical Trials
We have several clinical trials pending for liver disease. Click here to learn more about these.
Liver Disease Registry
Much advancement in medicine has resulted from research involving the collection and analysis of the medical record information of patients with a certain disease or condition. The Liver Disease Registry allows our researchers to gather information aimed at increasing our knowledge about liver disease and to help researchers identify and recruit patients who are eligible for participation in future research studies. For more information, contact our reasearch staff.
HCC Registry
Much advancement in medicine has resulted from research involving the collection and analysis of the medical record information of patients with a certain disease or condition. The Hepatocellular Carcinoma (HCC) Registry allows our researchers to gather information aimed at increasing our knowledge about liver cancer. For more information, contact our research staff.